Evonik has received the Responsible Care Award of the European Chemical Industry Council (Cefic) for its sustainable biosurfactants platform.
As the winner in the ‘Safe and Sustainable Chemicals' category, Evonik was recognized for its innovative glycolipid technology and strong partnership examples.
Evonik is the first company to develop an IP-protected biotechnological process to produce rhamnolipid biosurfactants at commercial scale.
In 2022, Evonik announced a triple-digit million-euro investment in a commercial-scale biosurfactant plant in Slovakia.
There is strong market demand for biosurfactants and a rapid transition to these sustainable surfactants is underway.
However, until recently, the commercial production of biosurfactants has been very challenging due to low yields in production processes and high recovery and purification costs.
Evonik’s sophorolipid and rhamnolipid biosurfactants are eco-friendly glycolipids that are commercially derived through a bio-fermentation process with a low carbon footprint, using a responsibly sourced and 100% renewable feedstock.
In addition to their strong sustainability profile, Evonik’s glycolipids have foaming, cleansing, and solubilizing properties that make them highly suitable for personal care applications such as shampoo and shower gel, and home care applications such as hand dishwashing, hard surface cleaning and laundry applications.
Further areas of application for biosurfactants are currently being evaluated.
“Together with our partners, we are changing the game for consumers and bringing sustainability into everyday products,” said Yann d'Hervé (pictured, right), head of Evonik's Care Solutions business line.
Founded in 1972, Cefic is the European Chemical Industry Council and is the voice of chemical companies across Europe.
Since 2005, the European Responsible Care Award has recognized the chemical industry’s work to improve safe chemicals management and achieve performance excellence.
